NeuroVive Pharmaceutical’s publication on Cells.
SMC announced that NeuroVive Pharmaceutical has published the results of a study using STAM™ model on International Journal of Molecular Sciences.
Title: “Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis”